Orchestra BioMed Holdings (OBIO) Current Leases (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Current Leases came in at $785000.0 in Q1 2026, up 33.05% year-on-year from $590000.0 in Q1 2025, and up 4.53% on a QoQ basis from $751000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Current Leases (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Current Leases data on file, last reported at $785000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 33.05% year-over-year to $785000.0 in Q1 2026; TTM through Mar 2026 was $785000.0, a 33.05% increase from a year earlier, with the FY2025 full-year figure at $751000.0, up 36.55% from the prior year.
- Current Leases for Q1 2026 stood at $785000.0, up from $751000.0 in the prior quarter.
- Over the last five years, Current Leases for OBIO reached as high as $785000.0 in Q1 2026 and fell as low as $350000.0 in Q2 2024.
- Historically, Current Leases has averaged $625500.0 across 5 years, with a median of $672500.0 in 2023.
- Across the five-year window, Current Leases sank 51.99% in 2024 and soared 83.43% in 2025, its largest moves.
- Year by year, Current Leases stood at $697000.0 in 2022, then retreated by 6.89% to $649000.0 in 2023, then retreated by 15.25% to $550000.0 in 2024, then soared by 36.55% to $751000.0 in 2025, then rose by 4.53% to $785000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $785000.0 in Q1 2026, $751000.0 in Q4 2025, and $696000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | 785,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 785,000.00 |
| Dec 31, 2025 | 751,000.00 |
| Sep 30, 2025 | 696,000.00 |
| Jun 30, 2025 | 642,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Sep 30, 2024 | 395,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Mar 31, 2024 | 465,000.00 |
| Dec 31, 2023 | 649,000.00 |
| Sep 30, 2023 | 747,000.00 |
| Jun 30, 2023 | 729,000.00 |
| Mar 31, 2023 | 711,000.00 |
| Dec 31, 2022 | 697,000.00 |